Page last updated: 2024-08-21

isoxazoles and Thrombocytopenia

isoxazoles has been researched along with Thrombocytopenia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's6 (60.00)29.6817
2010's1 (10.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Alibhai, D; Aungraheeta, MR; Burley, K; Collins, J; Cornish, N; Downes, K; FitzGibbon, L; Greene, D; Mumford, AD; Turro, E; Westbury, SK1
Fowler, N; Hagemeister, F; Knickerbocker, J; Kwak, L; Nastoupil, L; Oki, Y; Romaguera, J; Samaniego, F; Westin, J; Younes, A1
Huang, KY; Lai, NS; Liu, SQ; Lu, MC; Tung, CH; Yin, WY; Yu, CL1
Barrett, YC; Billheimer, JT; Cromley, DA; Daly, RN; Ebling, W; He, B; Hollis, GF; Hua, TA; Kieras, CJ; Pedicord, DL; Pieniaszek, HJ; Rossi, RJ; Seiffert, D; Sferruzza, A; Stein, RB; Stern, AM; Wynn, R1
Billheimer, JT; Breth, L; Dicker, I; Hollis, GF; O'Neil, K; Pedicord, DL; Seiffert, D; Stern, AM; Wynn, R1
Calcino, LJ; Hill, RL; McEwen, J; Purcell, PM; Riley, CG1
Ahmad, S; Mousa, SA1
Brown, T; Hidalgo, M; Kuhn, JG; MacGovren, JP; Rodriguez, G; Rowinsky, EK; Von Hoff, DD; Weiss, G1
Billheimer, JT; Bradley, JD; Cromley, DA; Daly, RN; Dicker, IB; Godonis, HE; Gorko, MA; Grimminger, LC; He, B; Hollis, GF; Kieras, CJ; Pedicord, DL; Seiffert, D; Spitz, SM; Stern, AM; Thomas, BE; Wynn, R; Zolotarjova, NI1
Eisenhauer, E; Evans, WK; Maroun, JA; Stewart, DJ; Verma, S1

Trials

3 trial(s) available for isoxazoles and Thrombocytopenia

ArticleYear
Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma.
    Haematologica, 2015, Volume: 100, Issue:7

    Topics: Antineoplastic Agents; Diarrhea; Drug Administration Schedule; Edema; Fatigue; Female; Gene Expression; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Recurrence; Remission Induction; Resorcinols; Retrospective Studies; Survival Analysis; Thrombocytopenia; Treatment Outcome

2015
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia.
    Blood, 2003, Jan-01, Volume: 101, Issue:1

    Topics: Amidines; Autoantibodies; Blood Platelets; Humans; Incidence; Isoxazoles; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Thrombocytopenia; Time Factors; Vascular Diseases

2003
A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:11

    Topics: Adult; Aged; Amino Acids; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Electrolytes; Female; Glucose; Glutamine; Humans; Isoxazoles; Male; Middle Aged; Neoplasms; Parenteral Nutrition Solutions; Solutions; Thrombocytopenia; Treatment Outcome

1998

Other Studies

7 other study(ies) available for isoxazoles and Thrombocytopenia

ArticleYear
Monoallelic loss-of-function THPO variants cause heritable thrombocytopenia.
    Blood advances, 2020, 03-10, Volume: 4, Issue:5

    Topics: Humans; Isoxazoles; Thrombocytopenia; Thrombopoietin

2020
Increased prevalence of polyomavirus BK viruria that correlates with thrombocytopenia in patients with systemic lupus erythematosus on intensive immunosuppressive therapy.
    Autoimmunity, 2009, Volume: 42, Issue:3

    Topics: Adult; Antiviral Agents; BK Virus; Female; Humans; Immunosuppression Therapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Male; Middle Aged; Polyomavirus Infections; Prevalence; Risk Factors; Thrombocytopenia; Urine; Young Adult

2009
CD32-dependent platelet activation by a drug-dependent antibody to glycoprotein IIb/IIIa antagonists.
    Thrombosis and haemostasis, 2003, Volume: 89, Issue:3

    Topics: Amidines; Animals; Antibodies, Monoclonal; Blood Platelets; Cysteine Endopeptidases; Humans; In Vitro Techniques; Isoxazoles; Mice; Neoplasm Proteins; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, IgG; Thrombocytopenia

2003
The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate.
    Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Anemia; Antirheumatic Agents; Australia; Carbamazepine; Child; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Humans; Incidence; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Neutropenia; Organogold Compounds; Pancytopenia; Thrombocytopenia

2007
Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.
    American journal of hematology, 2007, Volume: 82, Issue:4

    Topics: Amino Acids; Cells, Cultured; Heparin; Humans; Isoxazoles; Kruppel-Like Transcription Factors; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Repressor Proteins; Sensitivity and Specificity; Thrombocytopenia

2007
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated.
    Blood, 2002, May-15, Volume: 99, Issue:10

    Topics: Administration, Oral; Amidines; Animals; Antibodies; Biological Availability; Clinical Trials, Phase II as Topic; Enzyme-Linked Immunosorbent Assay; Epitopes; Humans; Isoxazoles; Kinetics; Pan troglodytes; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Sensitivity and Specificity; Thrombocytopenia

2002
Phase I study of acivicin and cisplatin in non-small-cell lung cancer. A National Cancer Institute of Canada study.
    American journal of clinical oncology, 1990, Volume: 13, Issue:5

    Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Government Agencies; Humans; Isoxazoles; Kidney; Lung Neoplasms; Male; Middle Aged; Remission Induction; Thrombocytopenia

1990